Cite
HARVARD Citation
Danzinger, S. et al. (2018). Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer. Cancer investigation. pp. 378-388. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Danzinger, S. et al. (2018). Differential Claudin 3 and EGFR Expression Predicts BRCA1 Mutation in Triple-Negative Breast Cancer. Cancer investigation. pp. 378-388. [Online].